LINC02828: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC02828

NCBI ID: G105374978

LINC02828

Other Name(s): long intergenic non-protein coding RNA 2828 | Long intergenic non-protein coding RNA 2828

LINC02828: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Introduction

LINC02828 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has a unique structure, length, and position in the genomic hierarchy, which has caught the attention of researchers due to its potential involvement in various biological processes. Although the primary function of LINC02828 is not well understood, several studies have hinted at its involvement in various cellular processes, including cell signaling, chromatin regulation, and metabolism. As a result, LINC02828 has been identified as a potential drug target or biomarker, which may offer new insights into the biology of human diseases.

Drug Target Potential

The drug targeting potential of LINC02828 is based on its unique structure and various functional assays. Firstly, LINC02828 has a unique 5'-end that is distinct from its 3'-end, which may be a feature that could influence its stability or localization in the cell. Additionally, LINC02828 contains a unique splicing event that is not observed in other lncRNAs, which may have implications for its processing and stability.

Furthermore, LINC02828 has been shown to play a role in the regulation of cellular processes that are crucial for human health, such as cell signaling, angiogenesis, and metabolism. For instance, LINC02828 has been shown to be involved in the regulation of theNotch signaling pathway , which is essential for normal brain development and function. Additionally, LINC02828 has been shown to be involved in the regulation of cell cycle progression, which is crucial for the regulation of cell growth and apoptosis.

Biomarker Potential

The biomarker potential of LINC02828 is based on its unique expression patterns and various functions in various biological processes. Firstly, LINC02828 has been shown to have a unique expression pattern in various tissues and organs, which may indicate its involvement in specific cellular processes. For instance , LINC02828 has been shown to be highly expressed in the brain, heart, and liver, which are critical for human health.

Secondly, LINC02828 has been shown to play a role in the regulation of various biological processes that are crucial for human health, such as cell signaling, metabolism, and inflammation. For instance, LINC02828 has been shown to be involved in the regulation of cell signaling pathways, including theNotch signaling pathway, which is essential for normal brain development and function. Additionally, LINC02828 has been shown to be involved in the regulation of metabolism, including the regulation of glucose metabolism.

Conclusion

In conclusion, LINC02828 is a long intergenic non-protein-coding RNA that has unique structure and function. Its unique expression pattern and involvement in various cellular processes make it a potential drug target or biomarker. Further studies are needed to fully understand the functional role of LINC02828 in various biological processes, including its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 2828

The "LINC02828 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02828 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets